gentamicin has been researched along with Bacterial Infections, Gram-Positive in 277 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current guidelines recommend either ampicillin plus ceftriaxone (AC) or amoxicillin/ampicillin plus gentamicin (AG) with an equivalent class IB recommendation in Enterococcus faecalis endocarditis." | 9.22 | Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. ( Hoppe, UC; Lichtenauer, M; Mirna, M; Schmutzler, L; Topf, A, 2022) |
| "The American Heart Association endorses penicillin G or ampicillin with gentamicin (A+G) or dual beta-lactam therapy with ampicillin and ceftriaxone (A+C) as first-line regimens for Enterococcus faecalis infective endocarditis (EFIE) caused by penicillin-susceptible isolates." | 8.12 | Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. ( Everson, N; Freeman, L; McDaniel, L; Milkovits, A, 2022) |
| "The pharmacokinetics of gentamicin in pediatric patients with febrile neutropenia is described, and the adequacy of initial dosing of once-daily gentamicin assessed at Queensland's largest Children's Hospital." | 7.83 | Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia. ( Bialkowski, S; Clark, J; Hennig, S; Lawson, R; Staatz, CE, 2016) |
| "Uncertainty exists regarding the role of synergistic gentamicin for uncomplicated Enterococcus faecalis bacteremia in children." | 7.81 | Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children. ( Brady, TM; Cosgrove, SE; Hsu, AJ; Ibrahim, SL; Tamma, PD; Zhang, L, 2015) |
| "The aim of this study was to assess changes in antibiotic resistance, epidemiology and outcome among patients with Enterococcus faecalis infective endocarditis (EFIE) and to compare the efficacy and safety of the combination of ampicillin and gentamicin (A+G) with that of ampicillin plus ceftriaxone (A+C)." | 7.80 | Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. ( Almela, M; Armero, Y; Castañeda, X; Cervera, C; del Rio, A; Falces, C; Garcia de la Maria, C; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D, 2014) |
| "The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for treating Enterococcus faecalis infective endocarditis (EFIE)." | 7.79 | Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. ( Almirante, B; de Alarcón, A; de la Torre, J; Falcone, M; Fernández-Hidalgo, N; Gálvez, J; Gavaldà, J; Gurgui, M; Hidalgo-Tenorio, C; Lomas, JM; López, J; López-Medrano, F; Martínez-Lacasa, X; Montejo, M; Pahissa, A; Peña, C; Plata, A; Ruiz, J; Sáez, C; Vallejo, N; Vilacosta, I, 2013) |
| "US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective endocarditis caused by staphylococci or enterococci, but once-daily dosing (3 mg/kg/day) is recommended for streptococcal endocarditis." | 7.78 | A survey on the use of gentamicin in infective endocarditis. ( Alfandari, S; Béraud, G; Couet, W; Elsendoorn, A; Godet, C; Le Moal, G; Roblot, F; Roblot, P; Tattevin, P, 2012) |
| "Gentamicin is often used to treat infective endocarditis (IE)." | 7.75 | Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. ( Bruun, NE; Buchholtz, K; Hassager, C; Larsen, CT, 2009) |
| " We describe successful treatment of persistent bacteremia caused by Enterococcus faecium with vancomycin and high-level gentamicin resistance in a 10-day-old former 23-week premature male infant." | 7.75 | Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant. ( Hapnes, N; Knowles, S; Twomey, A, 2009) |
| "Enterococcus spp bacteremia is associated with high mortality and the appearance of high-level gentamicin resistance (HLGR) created additional challenges for the treatment of these infections." | 7.74 | Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis. ( Bratfich, OJ; Moretti, ML; Oliveira, AM; Stucchi, RS; Vigani, AG, 2008) |
| "The objective of this study was to characterize the clinical and molecular epidemiology of Enterococcus faecalis bacteremia, specifically that involving strains with high-level resistance to gentamicin (HLGR)." | 7.69 | Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. ( Antalek, MD; Lesse, AJ; Mylotte, JM; Sellick, JA, 1995) |
| "The influence of the gentamicin dosing regimen was studied in experimental Enterococcus faecalis endocarditis." | 7.69 | Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. ( Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R, 1997) |
| "Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside." | 7.68 | Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992) |
| "In a retrospective analysis, patients with bacteremia due to Enterococcus faecalis with and without high-level gentamicin resistance (GRE; MIC greater than 2000 micrograms/ml) were compared." | 7.68 | High-level gentamicin resistance in Enterococcus faecalis bacteremia. ( Clarke, JT; Noskin, GA; Patterson, BK; Till, M; Warren, JR, 1991) |
| "Patients with enterococcal bacteremia due to strains with and without high-level gentamicin resistance (HLGR; MIC, > 2,000 mg/L) were compared." | 7.68 | Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. ( Patel, R; Watanakunakorn, C, 1993) |
| "Clinical features (except for chronic renal failure) were similar in both groups of patients." | 5.30 | Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. ( Caballero-Granado, FJ; Cisneros, JM; Díez, F; Gamboa, F; López-Ruz, MA; Luque, R; Menchero, A; Merino, D; Mora, D; Pasquau, J; Pérez-Cano, R; Torres-Tortosa, M; Vergara, A; Villanueva, JL, 1998) |
| "Current guidelines recommend either ampicillin plus ceftriaxone (AC) or amoxicillin/ampicillin plus gentamicin (AG) with an equivalent class IB recommendation in Enterococcus faecalis endocarditis." | 5.22 | Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. ( Hoppe, UC; Lichtenauer, M; Mirna, M; Schmutzler, L; Topf, A, 2022) |
| " Gentamicin has comparable efficacy to mupirocin for peritonitis and gram-positive exit-site infection." | 4.98 | Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis. ( Cheng, SP; Hsu, YC; Liu, CL; Tsai, CC; Wu, CJ; Yang, PS, 2018) |
| "This report expands on the number of cases of Leuconostoc bacteremia in pediatric patients with short bowel syndrome and shows that prior vancomycin is not a required risk factor for the development of this infection." | 4.84 | Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. ( Florescu, D; Hill, L; Iwen, PC; Sudan, D, 2008) |
| "The American Heart Association endorses penicillin G or ampicillin with gentamicin (A+G) or dual beta-lactam therapy with ampicillin and ceftriaxone (A+C) as first-line regimens for Enterococcus faecalis infective endocarditis (EFIE) caused by penicillin-susceptible isolates." | 4.12 | Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. ( Everson, N; Freeman, L; McDaniel, L; Milkovits, A, 2022) |
| " The diagnosis was based on the presence of vegetations on the bioprosthesis seen on the echocardiogram, positive blood cultures and fever, and a favorable clinical outcome following the treatment with ceftriaxone and gentamicin." | 4.02 | Aerococcus spp infective endocarditis following a prostate biopsy: a case report. ( Barbosa, DACK; Barros, MDNDDS; Carvalho, MH; Rodrigues, JV; Santos-Veloso, MAO, 2021) |
| "To define the clinical presentation of aerococcal infective endocarditis (IE) and the prevalence of synergy between penicillin and gentamicin on aerococcal isolates." | 3.83 | Clinical and microbiological features of infective endocarditis caused by aerococci. ( Nilson, B; Olaison, L; Rasmussen, M; Sunnerhagen, T, 2016) |
| "The pharmacokinetics of gentamicin in pediatric patients with febrile neutropenia is described, and the adequacy of initial dosing of once-daily gentamicin assessed at Queensland's largest Children's Hospital." | 3.83 | Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia. ( Bialkowski, S; Clark, J; Hennig, S; Lawson, R; Staatz, CE, 2016) |
| "Uncertainty exists regarding the role of synergistic gentamicin for uncomplicated Enterococcus faecalis bacteremia in children." | 3.81 | Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children. ( Brady, TM; Cosgrove, SE; Hsu, AJ; Ibrahim, SL; Tamma, PD; Zhang, L, 2015) |
| "The aim of this study was to assess changes in antibiotic resistance, epidemiology and outcome among patients with Enterococcus faecalis infective endocarditis (EFIE) and to compare the efficacy and safety of the combination of ampicillin and gentamicin (A+G) with that of ampicillin plus ceftriaxone (A+C)." | 3.80 | Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. ( Almela, M; Armero, Y; Castañeda, X; Cervera, C; del Rio, A; Falces, C; Garcia de la Maria, C; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D, 2014) |
| "The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for treating Enterococcus faecalis infective endocarditis (EFIE)." | 3.79 | Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. ( Almirante, B; de Alarcón, A; de la Torre, J; Falcone, M; Fernández-Hidalgo, N; Gálvez, J; Gavaldà, J; Gurgui, M; Hidalgo-Tenorio, C; Lomas, JM; López, J; López-Medrano, F; Martínez-Lacasa, X; Montejo, M; Pahissa, A; Peña, C; Plata, A; Ruiz, J; Sáez, C; Vallejo, N; Vilacosta, I, 2013) |
| "US and European guidelines recommend a daily divided gentamicin dose (3 mg/kg in two or three equally divided doses) for the treatment of infective endocarditis caused by staphylococci or enterococci, but once-daily dosing (3 mg/kg/day) is recommended for streptococcal endocarditis." | 3.78 | A survey on the use of gentamicin in infective endocarditis. ( Alfandari, S; Béraud, G; Couet, W; Elsendoorn, A; Godet, C; Le Moal, G; Roblot, F; Roblot, P; Tattevin, P, 2012) |
| "Empirical antibiotic treatment with a first-generation cephalosporin plus gentamicin for peritoneal dialysis (PD)-associated peritonitis before culture results are available is still wildly used due to concerns regarding the economic burden and antibiotic-resistant bacterial infections." | 3.76 | Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis. ( Chang, KC; Lee, CC; Sun, CY; Wu, MS, 2010) |
| "Gentamicin is often used to treat infective endocarditis (IE)." | 3.75 | Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. ( Bruun, NE; Buchholtz, K; Hassager, C; Larsen, CT, 2009) |
| " We describe successful treatment of persistent bacteremia caused by Enterococcus faecium with vancomycin and high-level gentamicin resistance in a 10-day-old former 23-week premature male infant." | 3.75 | Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant. ( Hapnes, N; Knowles, S; Twomey, A, 2009) |
| "Enterococcus spp bacteremia is associated with high mortality and the appearance of high-level gentamicin resistance (HLGR) created additional challenges for the treatment of these infections." | 3.74 | Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis. ( Bratfich, OJ; Moretti, ML; Oliveira, AM; Stucchi, RS; Vigani, AG, 2008) |
| "A 56-year old man with non-Hodgkin's lymphoma and biliary tract endoprosthesis, developed chronic bacteremia caused by Enterococcus faecalis with high-level resistance to gentamicin and streptomycin." | 3.70 | Fatal suppurative mesenteric thrombophlebitis caused by an Enterococcus faecalis highly resistant to aminoglycosides: case report. ( Brandimarte, C; Capone, A; Cassone, M; Galiè, M; Tarasi, A; Tarasi, D; Venditti, M, 1998) |
| "The objective of this study was to characterize the clinical and molecular epidemiology of Enterococcus faecalis bacteremia, specifically that involving strains with high-level resistance to gentamicin (HLGR)." | 3.69 | Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. ( Antalek, MD; Lesse, AJ; Mylotte, JM; Sellick, JA, 1995) |
| "The influence of the gentamicin dosing regimen was studied in experimental Enterococcus faecalis endocarditis." | 3.69 | Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. ( Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R, 1997) |
| "Patients with enterococcal bacteremia due to strains with and without high-level gentamicin resistance (HLGR; MIC, > 2,000 mg/L) were compared." | 3.68 | Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. ( Patel, R; Watanakunakorn, C, 1993) |
| "Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside." | 3.68 | Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992) |
| "In a retrospective analysis, patients with bacteremia due to Enterococcus faecalis with and without high-level gentamicin resistance (GRE; MIC greater than 2000 micrograms/ml) were compared." | 3.68 | High-level gentamicin resistance in Enterococcus faecalis bacteremia. ( Clarke, JT; Noskin, GA; Patterson, BK; Till, M; Warren, JR, 1991) |
| "Netilmicin also was more effective than gentamicin in eradicating infections (p = 0." | 2.70 | Treatment of acute bacterial conjunctivitis with topical netilmicin. ( Aragona, P; Blanco, AR; Di, BA; Milazzo, G; Papa, V; Santocono, M; Scuderi, AC; Zola, P, 2002) |
| "Isepamicin is a new aminoglycoside with in-vitro activity superior to amikacin." | 2.68 | Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. ( Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C, 1995) |
| " Therefore, in adult patients with a wide range of infections requiring aminoglycoside therapy, once-daily dosing with isepamicin is as effective as twice- daily dosing with amikacin." | 2.68 | Overview of the efficacy of isepamicin in the adult core clinical trial programme. ( Carbon, C, 1995) |
| " Several animal studies indicating effectiveness of penicillins for enterococcal endocarditis have used dosing regimens resulting in sustained serum levels." | 2.38 | Aminoglycoside resistant enterococcal endocarditis. ( Eliopoulos, GM, 1993) |
| "Ampicillin/ceftaroline was inferior to ampicillin/ ceftriaxone." | 1.56 | In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model. ( Hartung, A; Makarewicz, O; Pletz, MW; Thieme, L, 2020) |
| " The β-lactams showed a U-shape dose-response relationship in biofilm prevention." | 1.48 | In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis. ( Hartung, A; Klinger-Strobel, M; Makarewicz, O; Pletz, MW; Stein, C; Thieme, L, 2018) |
| "After emergency surgery for severe mitral regurgitation and antimicrobial treatment for 6 weeks, she was discharged from our hospital and is now being monitored at an out-patient clinic." | 1.46 | Postpartum infective endocarditis with Enterococcus faecalis in Japan: a case report. ( Asakura, M; Fujita, K; Kimizuka, S; Nakamura, S; Sasaki, M; Shoji, M; Sugawara, K; Suzuki, Y; Takahashi, Y; Tamura, M, 2017) |
| "In liver transplant (LT) recipients, surgical site infection (SSI) represents an important cause of morbidity and mortality." | 1.43 | Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients. ( Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M, 2016) |
| " This study systematically evaluated by in vitro time-kill studies the effect of daptomycin in combination with ampicillin, cefazolin, ceftriaxone, ceftaroline, ertapenem, gentamicin, tigecycline, and rifampin, for a collection of 9 daptomycin-NS enterococci that exhibited a broad range of MICs and different resistance-conferring mutations." | 1.42 | In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. ( Carvalho, M; Charlton, CL; Hindler, JA; Humphries, R; Kelesidis, T; Miller, SA; Nizet, V; Nonejuie, P; Pogliano, J; Sakoulas, G; Wong-Beringer, A, 2015) |
| "Gentamicin base release was evaluated in phosphate-buffered saline for up to 7 days using B." | 1.40 | Gentamicin palmitate as a new antibiotic formulation for mixing with bone tissue and local release. ( Coraça-Huber, DC; Fille, M; Hausdorfer, J; Kühn, KD; Nogler, M; Putzer, D, 2014) |
| " However, the optimal aminoglycoside or the optimal dosage remains uncertain." | 1.38 | The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. ( Asseray, N; Bugnon, D; Caillon, J; Dubé, L; Jacqueline, C; Potel, G, 2012) |
| "Gentamicin and linezolid were added to daptomycin therapy based on in vitro data synergy results and because of documented successful treatment for VRE meningitis, respectively." | 1.36 | Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. ( Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G, 2010) |
| "Vancomycin was administered in combination with high dose ampicillin and repeated blood cultures taken after administration of ampicillin, revealed no growth." | 1.35 | [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations]. ( Akduman, D; Aktaş, E; Aydemir, H; Celebi, G; Oztoprak, N; Pişkin, N, 2008) |
| "Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against gram-positive cocci, including enterococci." | 1.34 | Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. ( Arias, CA; Murray, BE; Panesso, D; Singh, KV, 2007) |
| " The aim of this study was to compare the therapeutic efficacy of quinupristin-dalfopristin (QD) alone, or in combination with gentamicin (G), teicoplanin (T), imipenem (I) or levofloxacin (L) against a strain of multidrug-resistant E." | 1.33 | [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium]. ( Gómez Gómez, J; López Fornás, F; Lorente Salinas, I; Martínez García, F; Pérez Salmerón, J; Roldán Conesa, D; Ruiz Gómez, J; Segovia Hernández, M; Valdés Chávarri, M, 2006) |
| "Disseminated anguilluliasis is a serious disease requiring early diagnosis and treatment." | 1.33 | [Meningitis caused by Enterococcus faecalis during disseminated anguilluliasis]. ( Catherinot, E; Meshaka, P; Nitenberg, G; Tankovic, J; Zahar, JR, 2006) |
| " This study determined the impact of human pharmacokinetic simulation (HPS) on gentamicin activity in an Enterococcus faecalis endocarditis model." | 1.32 | Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model. ( Bugnon, D; Caillon, J; Dubé, L; Granry, JC; Gras-Le Guen, C; Jacqueline, C; Kergueris, MF; Potel, G, 2003) |
| "To report a case of progressive necrotizing fasciitis of the face following acute dacryocystitis." | 1.32 | Facial necrotizing fasciitis following acute dacryocystitis. ( Lin, HC; Lin, PW, 2003) |
| "Vancomycin was excreted via bile into the stools of almost all patients at concentrations of 3." | 1.32 | Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. ( Currie, BP; Lemos-Filho, L, 2004) |
| "Gentamicin resistance was associated with conjugative plasmids (>70 kb) in most strains." | 1.32 | Genetic characterization of high-level gentamicin-resistant strains of Enterococcus faecalis in Iran. ( Asadi, S; Etemadi, G; Feizabadi, MM; Gharavi, S; Zohari, M, 2004) |
| " The possibility of pharmacokinetic interaction between G-CSF and each of the antibiotics was examined." | 1.31 | Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection. ( Bow, L; Nicolau, DP; Nightingale, CH; Onyeji, CO, 2000) |
| " In contrast, a higher dosing regimen of vancomycin (i." | 1.31 | Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis. ( Carbon, C; Courvalin, P; Fantin, B; Lafaurie, M; Lefort, A; Perichon, B, 2001) |
| "Trovafloxacin was 2-4 times more active than ciprofloxacin against both groups of strains." | 1.31 | Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin. ( Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM, 2001) |
| "Clinical features (except for chronic renal failure) were similar in both groups of patients." | 1.30 | Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. ( Caballero-Granado, FJ; Cisneros, JM; Díez, F; Gamboa, F; López-Ruz, MA; Luque, R; Menchero, A; Merino, D; Mora, D; Pasquau, J; Pérez-Cano, R; Torres-Tortosa, M; Vergara, A; Villanueva, JL, 1998) |
| "19 hours) to provide for safe and effective peak and trough cefazolin levels with postdialysis dosing in anuric hemodialysis patients." | 1.30 | Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. ( Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB, 1998) |
| "This investigation used checkerboard and time-kill assays to evaluate the in vitro activity of RPR 106972 (45% pristinamycin IB and 55% pristinamycin IIB) alone and in combination with vancomycin or ampicillin +/- gentamicin against multidrug-resistant enterococci." | 1.30 | In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci. ( Messick, CR; Pendland, SL; Woodward, J, 1998) |
| " faecalis clinical isolate, the animals received IFN-gamma, antibiotic or a combination of both agents, subcutaneously, at determined dosing regimens." | 1.30 | Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice. ( Bow, L; Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R, 1999) |
| " These findings validate the current NCCLS guideline for predicting synergistic activity against enterococci in strains with usual susceptibility to ampicillin, and suggest that a therapeutic level less than maximal recommended dosing is sufficient when using gentamicin in this setting." | 1.30 | Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines. ( Boschman, CR; Dressel, DC; Noskin, GA; Peterson, LR; Postelnick, MJ; Stosor, V; Tornatore-Reuscher, MA; Zembower, T, 1999) |
| "Clinafloxacin was tested against Enterococcus faecalis strain WH245, a beta-lactamase producer lacking high-level gentamicin resistance (MIC 12." | 1.29 | Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits. ( Donabedian, SA; Perri, MB; Thal, LA; Vazquez, J; Zervos, MJ, 1993) |
| "Streptomycin is an antimicrobial agent that must be used with vancomycin in serious infections to eradicate high-level, gentamicin-resistant S." | 1.29 | Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis. ( James, VE; Kays, MB; Kim-Sing, A; Weart, CW, 1993) |
| " The dosing interval of gentamicin did not significantly affect (q." | 1.29 | Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. ( Almirante, B; Capdevila, JA; Cardona, PJ; Crespo, E; Gavaldà, J; Laguarda, M; Pahissa, A; Pigrau, C; Pou, L, 1996) |
| "As gentamicin resistance has been described in other enterococcal species (E." | 1.29 | High-level gentamicin resistance among enterococci. ( Gilmore, MS; Sahm, DF, 1995) |
| "Spondylodiscitis by enterococci is an unusual disease with no therapeutic experience." | 1.29 | [Spondylodiscitis caused by Enterococcus: an unusual entity]. ( Capdevila, JA; Fernández-Solà, A; García Quintana, AM; García, F, 1995) |
| "Gentamicin resistance was transferred from four isolates to plasmid-free enterococcal recipients in filter matings." | 1.29 | Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance. ( Chow, JW; Clewell, DB; Donabedian, S; Patterson, JE; Perri, MB; Thal, LA; Zervos, MJ, 1993) |
| "Netilmicin was administered in combination with continuous infusions of amoxicillin, vancomycin, or penicillin against a bacterial biofilm adhering to glass beads." | 1.29 | Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model. ( Blaser, J; Schwank, S, 1996) |
| " Animals infected with strain SF-195 received 5 days of no therapy, ampicillin, ampicillin-gentamicin, vancomycin, or daptomycin (all at the dosage regimens described above)." | 1.28 | Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. ( Bayer, AS; Eliopoulos, GM; Grayson, ML; Ramos, MC, 1992) |
| "Gentamicin was the most active antibiotic with ED50 values of 0." | 1.26 | The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. ( Acred, P; Ryan, DM; Sowa, MA; Watts, CM, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.36) | 18.7374 |
| 1990's | 98 (35.38) | 18.2507 |
| 2000's | 87 (31.41) | 29.6817 |
| 2010's | 75 (27.08) | 24.3611 |
| 2020's | 16 (5.78) | 2.80 |
| Authors | Studies |
|---|---|
| Mirna, M | 1 |
| Topf, A | 1 |
| Schmutzler, L | 1 |
| Hoppe, UC | 1 |
| Lichtenauer, M | 1 |
| Freeman, L | 1 |
| Milkovits, A | 1 |
| McDaniel, L | 1 |
| Everson, N | 1 |
| Tumpa, A | 1 |
| Štritof, Z | 1 |
| Pintarić, S | 1 |
| Danneels, P | 1 |
| Hamel, JF | 1 |
| Picard, L | 1 |
| Rezig, S | 1 |
| Martinet, P | 1 |
| Lorleac'h, A | 1 |
| Talarmin, JP | 1 |
| Buzelé, R | 1 |
| Guimard, T | 1 |
| Le Moal, G | 2 |
| Brochard-Libois, J | 1 |
| Beaudron, A | 1 |
| Letheulle, J | 1 |
| Codde, C | 1 |
| Chenouard, R | 1 |
| Boutoille, D | 1 |
| Lemaignen, A | 1 |
| Bernard, L | 1 |
| Cattoir, V | 1 |
| Dubée, V | 2 |
| Luque-Paz, D | 1 |
| Cuervo, G | 1 |
| Miró, JM | 3 |
| Tattevin, P | 2 |
| Sharad, N | 1 |
| Srivastava, S | 1 |
| Ningombam, A | 1 |
| Malhotra, R | 1 |
| Mathur, P | 1 |
| Chilambi, GS | 1 |
| Wang, YH | 1 |
| Wallace, NR | 1 |
| Obiwuma, C | 1 |
| Evans, KM | 1 |
| Li, Y | 1 |
| Shalaby, MW | 1 |
| Flaherty, DP | 1 |
| Shields, RK | 1 |
| Doi, Y | 1 |
| Van Tyne, D | 1 |
| Haghi, F | 1 |
| Lohrasbi, V | 1 |
| Zeighami, H | 1 |
| Thieme, L | 2 |
| Hartung, A | 2 |
| Makarewicz, O | 2 |
| Pletz, MW | 2 |
| Rodrigues-Costa, F | 1 |
| Slivinski, J | 1 |
| Ióca, LP | 1 |
| Bertonha, AF | 1 |
| de Felício, R | 1 |
| Cunha, MGD | 1 |
| da Mata Madeira, PV | 1 |
| Cauz, ACG | 1 |
| Trindade, DM | 1 |
| Freire, VF | 1 |
| Ropke, CD | 1 |
| Gales, A | 1 |
| Brocchi, M | 1 |
| Ferreira, AG | 1 |
| Gueiros-Filho, F | 1 |
| Trivella, DBB | 1 |
| Berlinck, RGS | 1 |
| Dessen, A | 1 |
| Harada, S | 1 |
| Shibue, Y | 1 |
| Aoki, K | 1 |
| Ishii, Y | 1 |
| Tateda, K | 1 |
| Ramos-Martínez, A | 1 |
| Pericàs, JM | 2 |
| Fernández-Cruz, A | 1 |
| Muñoz, P | 1 |
| Valerio, M | 1 |
| Kestler, M | 1 |
| Montejo, M | 3 |
| Fariñas, MC | 1 |
| Sousa, D | 1 |
| Domínguez, F | 1 |
| Ojeda-Burgos, G | 1 |
| Plata, A | 2 |
| Vidal, L | 1 |
| Winther, M | 1 |
| Dalager-Pedersen, M | 1 |
| Tarpgaard, IH | 1 |
| Nielsen, HL | 1 |
| Shahini Shams Abadi, M | 1 |
| Taji, A | 1 |
| Salehi, F | 1 |
| Kazemian, H | 1 |
| Heidari, H | 1 |
| Santos-Veloso, MAO | 1 |
| Barros, MDNDDS | 1 |
| Carvalho, MH | 1 |
| Barbosa, DACK | 1 |
| Rodrigues, JV | 1 |
| Chen, YH | 2 |
| Lin, SY | 1 |
| Lin, YT | 1 |
| Tseng, SP | 1 |
| Chang, CC | 1 |
| Yu, SY | 1 |
| Hung, WW | 1 |
| Jao, YT | 1 |
| Lin, CY | 1 |
| Hung, WC | 1 |
| Ozma, MA | 1 |
| Khodadadi, E | 1 |
| Rezaee, MA | 1 |
| Kamounah, FS | 1 |
| Asgharzadeh, M | 1 |
| Ganbarov, K | 1 |
| Aghazadeh, M | 1 |
| Yousefi, M | 2 |
| Pirzadeh, T | 1 |
| Kafil, HS | 2 |
| Tsai, CC | 1 |
| Yang, PS | 1 |
| Liu, CL | 1 |
| Wu, CJ | 1 |
| Hsu, YC | 1 |
| Cheng, SP | 1 |
| Gil-Navarro, MV | 1 |
| Lopez-Cortes, LE | 1 |
| Luque-Marquez, R | 1 |
| Galvez-Acebal, J | 1 |
| de Alarcon-Gonzalez, A | 1 |
| Tamura, M | 1 |
| Shoji, M | 1 |
| Fujita, K | 1 |
| Nakamura, S | 1 |
| Takahashi, Y | 1 |
| Suzuki, Y | 1 |
| Asakura, M | 1 |
| Kimizuka, S | 1 |
| Sasaki, M | 1 |
| Sugawara, K | 1 |
| Klinger-Strobel, M | 1 |
| Stein, C | 1 |
| Karlović, K | 1 |
| Nikolić, J | 1 |
| Arapović, J | 1 |
| El Rafei, A | 1 |
| DeSimone, DC | 1 |
| Narichania, AD | 1 |
| Sohail, MR | 1 |
| Vikram, HR | 1 |
| Li, Z | 1 |
| Steckelberg, JM | 2 |
| Wilson, WR | 1 |
| Baddour, LM | 1 |
| Zhang, JM | 1 |
| Wang, Q | 1 |
| Han, TY | 1 |
| Liu, JH | 1 |
| Hu, XX | 1 |
| Qiao, F | 1 |
| Yang, XY | 1 |
| Li, CR | 1 |
| You, XF | 1 |
| Jent, P | 1 |
| Thalmann, L | 1 |
| Pabst, T | 1 |
| Droz, S | 1 |
| Sendi, P | 1 |
| Horsley, H | 1 |
| Owen, J | 1 |
| Browning, R | 1 |
| Carugo, D | 1 |
| Malone-Lee, J | 1 |
| Stride, E | 1 |
| Rohn, JL | 1 |
| Malek, A | 1 |
| De la Hoz, A | 1 |
| Gomez-Villegas, SI | 1 |
| Nowbakht, C | 1 |
| Arias, CA | 5 |
| Zalipour, M | 1 |
| Esfahani, BN | 1 |
| Havaei, SA | 1 |
| Costa, LBD | 1 |
| Corá, LF | 1 |
| Correa, FEL | 1 |
| Gabrielli, LC | 1 |
| de Oliveira, MR | 1 |
| Conceição, N | 1 |
| Oliveira, AG | 1 |
| Weichman, KE | 1 |
| Levine, SM | 1 |
| Wilson, SC | 1 |
| Choi, M | 1 |
| Karp, NS | 1 |
| Dahl, A | 1 |
| Rasmussen, RV | 1 |
| Bundgaard, H | 1 |
| Hassager, C | 2 |
| Bruun, LE | 1 |
| Lauridsen, TK | 1 |
| Moser, C | 1 |
| Sogaard, P | 1 |
| Arpi, M | 1 |
| Bruun, NE | 2 |
| Pontikis, K | 1 |
| Pefanis, A | 1 |
| Tsaganos, T | 1 |
| Tzepi, IM | 1 |
| Carrer, DP | 1 |
| Giamarellou, H | 1 |
| Franko, B | 1 |
| Vaillant, M | 1 |
| Recule, C | 1 |
| Vautrin, E | 1 |
| Brion, JP | 1 |
| Pavese, P | 1 |
| Dadfarma, N | 1 |
| Imani Fooladi, AA | 1 |
| Oskoui, M | 1 |
| Mahmoodzadeh Hosseini, H | 1 |
| Choi, JM | 1 |
| Woo, GJ | 1 |
| Gelfand, MS | 1 |
| Cleveland, KO | 1 |
| Fernández-Hidalgo, N | 2 |
| Almirante, B | 4 |
| Pahissa, A | 4 |
| Solla, DJ | 1 |
| Dinubile, MJ | 1 |
| Coraça-Huber, DC | 1 |
| Putzer, D | 1 |
| Fille, M | 1 |
| Hausdorfer, J | 1 |
| Nogler, M | 1 |
| Kühn, KD | 1 |
| Bassetti, M | 1 |
| Righi, E | 1 |
| Crapis, M | 1 |
| Cojutti, P | 1 |
| Venturini, S | 1 |
| Viale, P | 1 |
| Pea, F | 1 |
| García-Vázquez, E | 1 |
| Albendín, H | 1 |
| Hernández-Torres, A | 1 |
| Canteras, M | 1 |
| Yagüe, G | 1 |
| Ruiz, J | 2 |
| Gómez, J | 1 |
| Oliva, A | 1 |
| Furustrand Tafin, U | 2 |
| Maiolo, EM | 1 |
| Jeddari, S | 1 |
| Bétrisey, B | 2 |
| Trampuz, A | 2 |
| Ahmad, SS | 1 |
| Huber, K | 1 |
| Evangelopoulos, DS | 1 |
| Kleer, B | 1 |
| Kohlhof, H | 1 |
| Schär, M | 1 |
| Eggli, S | 1 |
| Kohl, S | 1 |
| Saidane, O | 1 |
| Mahmoud, I | 1 |
| Saadi, F | 1 |
| Souayah, A | 1 |
| Zouari, R | 1 |
| Chowdhury, SA | 1 |
| Nallapareddy, SR | 1 |
| Murray, BE | 9 |
| Corona, PS | 1 |
| Espinal, L | 1 |
| Rodríguez-Pardo, D | 1 |
| Pigrau, C | 3 |
| Larrosa, N | 1 |
| Flores, X | 1 |
| Charlagorla, P | 1 |
| Sublett, S | 1 |
| Sy, F | 1 |
| Kessler, E | 1 |
| Gad, A | 1 |
| Cárdenas, AM | 1 |
| Andreacchio, KA | 1 |
| Edelstein, PH | 1 |
| Cervera, C | 1 |
| del Rio, A | 1 |
| Moreno, A | 1 |
| Garcia de la Maria, C | 1 |
| Almela, M | 1 |
| Falces, C | 1 |
| Ninot, S | 1 |
| Castañeda, X | 1 |
| Armero, Y | 1 |
| Soy, D | 1 |
| Gatell, JM | 1 |
| Marco, F | 1 |
| Mestres, CA | 1 |
| Soriano, A | 1 |
| Mansour, R | 1 |
| Horovitz, Y | 1 |
| Amital, H | 1 |
| Aamodt, H | 1 |
| Mohn, SC | 2 |
| Maselle, S | 1 |
| Manji, KP | 1 |
| Willems, R | 1 |
| Jureen, R | 2 |
| Langeland, N | 2 |
| Blomberg, B | 1 |
| Hindler, JA | 1 |
| Wong-Beringer, A | 1 |
| Charlton, CL | 1 |
| Miller, SA | 1 |
| Kelesidis, T | 1 |
| Carvalho, M | 1 |
| Sakoulas, G | 2 |
| Nonejuie, P | 1 |
| Pogliano, J | 1 |
| Nizet, V | 1 |
| Humphries, R | 1 |
| Hernigou, J | 1 |
| Gordienco, A | 1 |
| Dakhil, B | 1 |
| Longuet, P | 1 |
| Couffinhal, JC | 1 |
| Bagan, P | 1 |
| Ibrahim, SL | 1 |
| Zhang, L | 1 |
| Brady, TM | 1 |
| Hsu, AJ | 1 |
| Cosgrove, SE | 1 |
| Tamma, PD | 1 |
| Van Driest, S | 1 |
| Goldman, JL | 1 |
| Sunnerhagen, T | 1 |
| Nilson, B | 1 |
| Olaison, L | 1 |
| Rasmussen, M | 1 |
| Chen, CH | 1 |
| Yang, CW | 1 |
| Li, CT | 1 |
| Hsiu, RH | 1 |
| Mobarez, AM | 1 |
| Moghadam, MF | 1 |
| Hashemi, ZS | 1 |
| Rasool, MH | 1 |
| Siddique, AB | 1 |
| Saqalein, M | 1 |
| Asghar, MJ | 1 |
| Zahoor, MA | 1 |
| Aslam, B | 1 |
| Shafiq, HB | 1 |
| Nisar, MA | 1 |
| El-Kersh, TA | 1 |
| Marie, MA | 1 |
| Al-Sheikh, YA | 1 |
| Al-Agamy, MH | 1 |
| Al Bloushy, AA | 1 |
| Prieto, J | 1 |
| Medina, JC | 1 |
| López, M | 1 |
| Rando, K | 1 |
| Iglesias, C | 1 |
| Harguindeguy, M | 1 |
| Leites, A | 1 |
| Etlin, A | 1 |
| Menéndez, J | 1 |
| Valverde, M | 1 |
| Scalone, P | 1 |
| Castelli, J | 1 |
| Grecco, G | 1 |
| Abelleira, M | 1 |
| González, LS | 1 |
| Gerona, S | 1 |
| Tracy, SI | 1 |
| Brown, SA | 1 |
| Ratelle, JT | 1 |
| Bhagra, A | 1 |
| Hirzel, C | 1 |
| Hirzberger, L | 1 |
| Furrer, H | 1 |
| Endimiani, A | 1 |
| Bialkowski, S | 1 |
| Staatz, CE | 1 |
| Clark, J | 1 |
| Lawson, R | 1 |
| Hennig, S | 1 |
| Mouyis, K | 1 |
| Metaxa, S | 1 |
| Missouris, C | 1 |
| Emaneini, M | 1 |
| Khoramian, B | 1 |
| Jabalameli, F | 1 |
| Beigverdi, R | 1 |
| Asadollahi, K | 1 |
| Taherikalani, M | 1 |
| Lari, AR | 1 |
| Lee, JH | 1 |
| Yoon, JH | 1 |
| Kim, BH | 1 |
| Chung, GE | 1 |
| Myung, SJ | 1 |
| Kim, W | 1 |
| Kim, YJ | 1 |
| Kim, EC | 2 |
| Lee, HS | 1 |
| Pişkin, N | 1 |
| Akduman, D | 1 |
| Aydemir, H | 1 |
| Celebi, G | 1 |
| Oztoprak, N | 1 |
| Aktaş, E | 1 |
| Florescu, D | 1 |
| Hill, L | 1 |
| Sudan, D | 1 |
| Iwen, PC | 2 |
| Medaghri-Alaoui, T | 1 |
| Angoulvant, D | 1 |
| Celard, M | 1 |
| André-Fouët, X | 1 |
| Feizabadi, MM | 2 |
| Shokrzadeh, L | 1 |
| Sayady, S | 1 |
| Asadi, S | 2 |
| Vigani, AG | 1 |
| Oliveira, AM | 1 |
| Bratfich, OJ | 1 |
| Stucchi, RS | 1 |
| Moretti, ML | 1 |
| Abbott, Y | 1 |
| Kirby, BM | 1 |
| Karczmarczyk, M | 1 |
| Markey, BK | 1 |
| Leonard, FC | 1 |
| Fitzgerald, S | 1 |
| Buchholtz, K | 1 |
| Larsen, CT | 1 |
| Whittaker, JP | 1 |
| Warren, RE | 1 |
| Jones, RS | 1 |
| Gregson, PA | 1 |
| Hapnes, N | 1 |
| Twomey, A | 1 |
| Knowles, S | 1 |
| Mato, R | 1 |
| Almeida, F | 1 |
| Pires, R | 1 |
| Rodrigues, P | 1 |
| Ferreira, T | 1 |
| Santos-Sanches, I | 1 |
| Szeto, CC | 1 |
| Kwan, BC | 1 |
| Chow, KM | 1 |
| Law, MC | 1 |
| Pang, WF | 1 |
| Chung, KY | 1 |
| Leung, CB | 1 |
| Li, PK | 1 |
| Laguna Del Estal, P | 1 |
| García Zubiri, C | 1 |
| García Madero, R | 1 |
| Gil Navarro, M | 1 |
| Saifi, M | 1 |
| Pourshafie, MR | 1 |
| Dallal, MM | 1 |
| Katouli, M | 1 |
| Watanabe, S | 1 |
| Kobayashi, N | 1 |
| Quiñones, D | 1 |
| Nagashima, S | 1 |
| Uehara, N | 1 |
| Watanabe, N | 1 |
| Acred, P | 1 |
| Ryan, DM | 1 |
| Sowa, MA | 1 |
| Watts, CM | 1 |
| Steenbergen, JN | 1 |
| Mohr, JF | 1 |
| Thorne, GM | 1 |
| Pérez Rodríguez, MT | 1 |
| Sopeña, B | 1 |
| Lueiro, F | 1 |
| Martínez-Vázquez, C | 1 |
| Weckwerth, PH | 1 |
| de Magalhães Lopes, CA | 1 |
| Duarte, MA | 1 |
| Weckwerth, AC | 1 |
| Martins, CH | 1 |
| Neto, DL | 1 |
| de Aguiar, HF | 1 |
| Jang, HC | 1 |
| Lee, S | 1 |
| Song, KH | 1 |
| Jeon, JH | 1 |
| Park, WB | 1 |
| Park, SW | 1 |
| Kim, HB | 1 |
| Kim, NJ | 1 |
| Oh, MD | 1 |
| Choe, KW | 1 |
| Larsen, J | 2 |
| Schønheyder, HC | 3 |
| Lester, CH | 4 |
| Olsen, SS | 2 |
| Porsbo, LJ | 1 |
| Garcia-Migura, L | 1 |
| Jensen, LB | 1 |
| Bisgaard, M | 1 |
| Hammerum, AM | 4 |
| Lee, CC | 1 |
| Sun, CY | 1 |
| Chang, KC | 1 |
| Wu, MS | 1 |
| Heuer, OE | 1 |
| Kwon, SH | 1 |
| Oh, JH | 1 |
| Hwang, SJ | 1 |
| Kim, SJ | 1 |
| Kim, WS | 1 |
| Kim, MG | 1 |
| Kim, KS | 1 |
| Hartmann, C | 1 |
| Peter, C | 1 |
| Hermann, E | 1 |
| Ure, B | 1 |
| Sedlacek, L | 1 |
| Hansen, G | 1 |
| Bohnhorst, B | 1 |
| Guardabassi, L | 1 |
| Skov, R | 1 |
| Chau, F | 1 |
| Arthur, M | 2 |
| Garry, L | 2 |
| Benadda, S | 1 |
| Mesnage, S | 1 |
| Lefort, A | 3 |
| Fantin, B | 3 |
| Le, J | 1 |
| Bookstaver, PB | 1 |
| Rudisill, CN | 1 |
| Hashem, MG | 1 |
| Iqbal, R | 1 |
| James, CL | 1 |
| Sambhav, K | 1 |
| Mathai, A | 1 |
| Reddy, AK | 1 |
| Reddy, BV | 1 |
| Bhatia, K | 1 |
| Balne, PK | 1 |
| Fitzgibbons, LN | 1 |
| Puls, DL | 1 |
| Mackay, K | 1 |
| Forrest, GN | 1 |
| Wilbring, M | 1 |
| Alexiou, K | 1 |
| Reichenspurner, H | 1 |
| Matschke, K | 1 |
| Tugtekin, SM | 1 |
| Mercuri, LG | 1 |
| Psutka, D | 1 |
| Majic, I | 1 |
| Zalila Belkhodja, C | 1 |
| Corvec, S | 1 |
| Zimmerli, W | 1 |
| Béraud, G | 1 |
| Elsendoorn, A | 1 |
| Godet, C | 1 |
| Alfandari, S | 1 |
| Couet, W | 1 |
| Roblot, P | 1 |
| Roblot, F | 1 |
| Holm, A | 1 |
| Hansen, DS | 1 |
| Dubé, L | 2 |
| Caillon, J | 2 |
| Jacqueline, C | 2 |
| Bugnon, D | 2 |
| Potel, G | 2 |
| Asseray, N | 1 |
| Rosvoll, TC | 1 |
| Lindstad, BL | 1 |
| Lunde, TM | 1 |
| Hegstad, K | 1 |
| Aasnaes, B | 1 |
| Simonsen, GS | 4 |
| Sundsfjord, A | 3 |
| Pedersen, T | 1 |
| Giuliano, S | 1 |
| Caccese, R | 1 |
| Carfagna, P | 1 |
| Vena, A | 1 |
| Falcone, M | 2 |
| Venditti, M | 3 |
| Lo, WB | 1 |
| Patel, M | 1 |
| Solanki, GA | 1 |
| Walsh, AR | 1 |
| Poi, MJ | 1 |
| Pisimisis, G | 1 |
| Barshes, NR | 1 |
| Darouiche, RO | 1 |
| Lin, PH | 1 |
| Kougias, P | 1 |
| Bechara, CF | 1 |
| Gavaldà, J | 3 |
| Gurgui, M | 1 |
| Peña, C | 1 |
| de Alarcón, A | 1 |
| Vilacosta, I | 1 |
| Vallejo, N | 1 |
| López-Medrano, F | 1 |
| López, J | 1 |
| Hidalgo-Tenorio, C | 1 |
| Gálvez, J | 1 |
| Sáez, C | 1 |
| Lomas, JM | 1 |
| de la Torre, J | 1 |
| Martínez-Lacasa, X | 1 |
| Munita, JM | 1 |
| Simjee, S | 2 |
| White, DG | 1 |
| McDermott, PF | 1 |
| Wagner, DD | 1 |
| Zervos, MJ | 12 |
| Donabedian, SM | 5 |
| English, LL | 1 |
| Hayes, JR | 1 |
| Walker, RD | 1 |
| Småbrekke, L | 1 |
| Monnet, DL | 1 |
| Sørensen, TL | 1 |
| Møller, JK | 1 |
| Kristinsson, KG | 1 |
| Lagerqvist-Widh, A | 1 |
| Torell, E | 1 |
| Digranes, A | 2 |
| Harthug, S | 2 |
| Shrestha, NK | 1 |
| Gordon, SM | 1 |
| Isada, CM | 1 |
| Flores, C | 1 |
| Maguilnik, I | 1 |
| Hadlich, E | 1 |
| Goldani, LZ | 1 |
| Thal, LA | 5 |
| Hershberger, E | 1 |
| Perri, MB | 5 |
| Chow, JW | 9 |
| Bartlett, P | 1 |
| Jones, R | 1 |
| Joyce, K | 1 |
| Rossiter, S | 1 |
| Gay, K | 1 |
| Johnson, J | 1 |
| Mackinson, C | 1 |
| Debess, E | 1 |
| Madden, J | 1 |
| Angulo, F | 1 |
| Fluit, AC | 1 |
| Florijn, A | 1 |
| Verhoef, J | 1 |
| Schmitz, FJ | 1 |
| Murdoch, DR | 1 |
| Mirrett, S | 1 |
| Harrell, LJ | 1 |
| Reller, LB | 1 |
| Lin, PW | 1 |
| Lin, HC | 1 |
| Thompson, RL | 1 |
| Lavin, B | 1 |
| Talbot, GH | 1 |
| Gras-Le Guen, C | 1 |
| Kergueris, MF | 1 |
| Granry, JC | 1 |
| Daikos, GL | 1 |
| Bamias, G | 1 |
| Kattamis, C | 1 |
| Christakis, G | 1 |
| Petrikkos, G | 1 |
| Triantafyllopoulou, P | 1 |
| Alexandrou, H | 1 |
| Syriopoulou, V | 1 |
| Stepanović, S | 1 |
| Jovanović, M | 1 |
| Lavadinović, L | 1 |
| Stošović, B | 1 |
| Pelemiš, M | 1 |
| Grinda, JM | 1 |
| Brazille, P | 1 |
| Bricourt, MO | 1 |
| Mainardi, JL | 1 |
| Gonzales-Canali, G | 1 |
| Piketti, C | 1 |
| Deloche, A | 1 |
| Saeedi, B | 1 |
| Hällgren, A | 1 |
| Isaksson, B | 1 |
| Jonasson, J | 1 |
| Nilsson, LE | 1 |
| Hanberger, H | 1 |
| Tascini, C | 1 |
| Doria, R | 1 |
| Leonildi, A | 1 |
| Martinelli, C | 1 |
| Menichetti, F | 2 |
| Currie, BP | 1 |
| Lemos-Filho, L | 1 |
| Kaiser, AM | 1 |
| Schultsz, C | 1 |
| Kruithof, GJ | 1 |
| Debets-Ossenkopp, Y | 1 |
| Vandenbroucke-Grauls, C | 1 |
| Hashimoto, T | 1 |
| Jodo, S | 1 |
| Furusaki, A | 1 |
| Kon, Y | 1 |
| Amasaki, Y | 1 |
| Atsumi, T | 1 |
| Komatsu, H | 1 |
| Shimokawa, J | 1 |
| Yonezawa, K | 1 |
| Koike, T | 1 |
| Zohari, M | 1 |
| Gharavi, S | 1 |
| Etemadi, G | 1 |
| Takeuchi, K | 1 |
| Tomita, H | 2 |
| Fujimoto, S | 2 |
| Kudo, M | 2 |
| Kuwano, H | 1 |
| Ike, Y | 3 |
| Harada, T | 1 |
| Tsuji, N | 1 |
| Otsuki, K | 1 |
| Murase, T | 1 |
| East, JE | 1 |
| Foweraker, JE | 1 |
| Murgatroyd, FD | 1 |
| Rodríguez-Baño, J | 1 |
| Ramírez, E | 1 |
| Muniain, MA | 1 |
| Santos, J | 1 |
| Joyanes, P | 1 |
| González, F | 1 |
| García-Sánchez, M | 1 |
| Martínez-Martínez, L | 1 |
| Qu, TT | 1 |
| Chen, YG | 1 |
| Yu, YS | 1 |
| Wei, ZQ | 1 |
| Zhou, ZH | 1 |
| Li, LJ | 1 |
| Wareham, DW | 1 |
| Abbas, H | 1 |
| Karcher, AM | 1 |
| Das, SS | 4 |
| Zarrilli, R | 1 |
| Tripodi, MF | 2 |
| Di Popolo, A | 1 |
| Fortunato, R | 1 |
| Bagattini, M | 1 |
| Crispino, M | 1 |
| Florio, A | 1 |
| Triassi, M | 1 |
| Utili, R | 2 |
| Zahar, JR | 1 |
| Tankovic, J | 1 |
| Catherinot, E | 1 |
| Meshaka, P | 1 |
| Nitenberg, G | 1 |
| Sandoe, JA | 1 |
| Wysome, J | 1 |
| West, AP | 1 |
| Heritage, J | 1 |
| Wilcox, MH | 1 |
| Tekin, A | 1 |
| Tekin, G | 1 |
| Turunç, T | 1 |
| Demiroğlu, Z | 1 |
| Kizilkiliç, O | 1 |
| Filipová, M | 1 |
| Bujdákova, H | 1 |
| Drahovská, H | 1 |
| Lisková, A | 1 |
| Hanzen, J | 1 |
| Titze-de-Almeida, R | 1 |
| Van Belkum, A | 2 |
| Felipe, MS | 1 |
| Zanella, RC | 1 |
| Top, J | 1 |
| Willems, RJ | 1 |
| Klibi, N | 2 |
| Ben Slama, K | 2 |
| Masmoudi, A | 2 |
| Gharbi, S | 1 |
| Ruiz-Larrea, F | 1 |
| Fendri, C | 1 |
| Boudabous, A | 2 |
| Torres, C | 4 |
| Pérez Salmerón, J | 1 |
| Martínez García, F | 1 |
| Roldán Conesa, D | 1 |
| Lorente Salinas, I | 1 |
| López Fornás, F | 1 |
| Ruiz Gómez, J | 1 |
| Gómez Gómez, J | 1 |
| Segovia Hernández, M | 1 |
| Valdés Chávarri, M | 1 |
| Sucu, N | 1 |
| Köksal, I | 1 |
| Yilmaz, G | 1 |
| Aydin, K | 1 |
| Caylan, R | 1 |
| Aktoz Boz, G | 1 |
| Chang, PC | 1 |
| Li, HY | 1 |
| Tang, HJ | 1 |
| Liu, JW | 1 |
| Wang, JJ | 1 |
| Chuang, YC | 1 |
| Abbassi, MS | 1 |
| Achour, W | 1 |
| Hassen, AB | 1 |
| Singh, KV | 5 |
| Panesso, D | 2 |
| Starr, JA | 1 |
| Sáenz, Y | 1 |
| Zanetti, S | 1 |
| Sechi, LA | 1 |
| Barber, GR | 1 |
| Lauretta, J | 1 |
| Saez, R | 1 |
| Torres, HA | 1 |
| Moore, J | 1 |
| Wanger, A | 1 |
| Yean, CY | 1 |
| Yin, LS | 1 |
| Lalitha, P | 1 |
| Ravichandran, M | 1 |
| Sekar, R | 1 |
| Srivani, R | 1 |
| Vignesh, R | 1 |
| Kownhar, H | 1 |
| Shankar, EM | 1 |
| Afshari, NA | 1 |
| Ma, JJ | 1 |
| Duncan, SM | 1 |
| Pineda, R | 1 |
| Starr, CE | 1 |
| Decroos, FC | 1 |
| Johnson, CS | 1 |
| Adelman, RA | 1 |
| Wade, JJ | 2 |
| Gallemore, GH | 1 |
| Mohon, RT | 1 |
| Ferguson, DA | 1 |
| Lee, PY | 2 |
| Antalek, MD | 1 |
| Mylotte, JM | 1 |
| Lesse, AJ | 1 |
| Sellick, JA | 1 |
| Coque, TM | 1 |
| Patterson, JE | 2 |
| Fazal, BA | 1 |
| Turett, GS | 1 |
| Chilimuri, SS | 1 |
| Mendoza, CM | 1 |
| Telzak, EE | 1 |
| Woodford, N | 4 |
| Jones, BL | 1 |
| Baccus, Z | 1 |
| Ludlam, HA | 1 |
| Brown, DF | 1 |
| McNamara, EB | 1 |
| King, EM | 1 |
| Smyth, EG | 1 |
| Caron, F | 4 |
| Pestel, M | 1 |
| Kitzis, MD | 1 |
| Lemeland, JF | 2 |
| Humbert, G | 2 |
| Gutmann, L | 3 |
| Jett, BD | 1 |
| Jensen, HG | 1 |
| Atkuri, RV | 1 |
| Gilmore, MS | 2 |
| Anderson, JR | 1 |
| Macdonald, AA | 1 |
| Somerville, KW | 1 |
| Morrison, D | 2 |
| Cookson, B | 1 |
| George, RC | 1 |
| Vazquez, J | 1 |
| Donabedian, SA | 2 |
| Montravers, P | 1 |
| Andremont, A | 1 |
| Massias, L | 1 |
| Carbon, C | 5 |
| Landman, D | 1 |
| Mobarakai, NK | 1 |
| Quale, JM | 1 |
| Whitman, MS | 1 |
| Pitsakis, PG | 1 |
| Zausner, A | 1 |
| Livornese, LL | 1 |
| Osborne, AJ | 1 |
| Johnson, CC | 1 |
| Levison, ME | 1 |
| Tenorio, C | 2 |
| Lantero, M | 1 |
| Gastañares, MJ | 1 |
| Baquero, F | 1 |
| McDonald, GR | 1 |
| Handwerger, S | 1 |
| Raucher, B | 1 |
| Altarac, D | 1 |
| Monka, J | 1 |
| Marchione, S | 1 |
| Wolff, J | 1 |
| Walters, B | 1 |
| Kim-Sing, A | 1 |
| Kays, MB | 1 |
| James, VE | 1 |
| Weart, CW | 1 |
| Megran, DW | 1 |
| Bantar, CE | 1 |
| Micucci, M | 1 |
| Fernandez Canigia, L | 1 |
| Smayevsky, J | 1 |
| Bianchini, HM | 1 |
| Watanakunakorn, C | 1 |
| Patel, R | 1 |
| Guiney, M | 2 |
| Urwin, G | 2 |
| Klare, I | 1 |
| Eliopoulos, GM | 4 |
| Lavoie, SR | 1 |
| Wong, ES | 2 |
| Coudron, PE | 3 |
| Williams, DS | 2 |
| Markowitz, SM | 3 |
| Donabedian, S | 1 |
| Clewell, DB | 2 |
| Bhattacharya, M | 1 |
| Warren, JR | 2 |
| Zajdowicz, T | 1 |
| Stevens, PJ | 1 |
| Mahayni, R | 1 |
| Bonilla, H | 1 |
| Silverman, J | 2 |
| Taber, S | 1 |
| García, F | 1 |
| Fernández-Solà, A | 1 |
| García Quintana, AM | 1 |
| Capdevila, JA | 2 |
| Sahm, DF | 3 |
| Herbrecht, R | 1 |
| Blaise, D | 1 |
| Espinouse, D | 1 |
| Leblond, V | 1 |
| Sadoun, A | 1 |
| Sauvage, C | 1 |
| Cordonnier, C | 1 |
| Minozzi, C | 1 |
| Antony, SJ | 1 |
| Matherin, P | 1 |
| Stratton, C | 1 |
| Vijayvargiya, R | 1 |
| Veis, JH | 1 |
| Cardona, PJ | 1 |
| Laguarda, M | 1 |
| Pou, L | 2 |
| Crespo, E | 1 |
| Seetulsingh, PS | 1 |
| Tomayko, JF | 1 |
| Skinner, C | 1 |
| Tan, DT | 1 |
| Lee, CP | 1 |
| Lim, AS | 1 |
| Schwank, S | 1 |
| Blaser, J | 1 |
| Keddy, KH | 1 |
| Klugman, KP | 1 |
| Liebowitz, LD | 1 |
| Davidson, A | 1 |
| Sanford, E | 1 |
| Shiojima, M | 1 |
| Tanimoto, K | 2 |
| Lavery, A | 1 |
| Rossney, AS | 1 |
| Power, A | 1 |
| Keane, CT | 1 |
| Marangos, MN | 1 |
| Nicolau, DP | 5 |
| Quintiliani, R | 2 |
| Nightingale, CH | 5 |
| Espinoza, R | 1 |
| Kusne, S | 1 |
| Pasculle, AW | 1 |
| Wada, S | 1 |
| Fung, J | 1 |
| Rakela, J | 1 |
| Straut, M | 1 |
| de Cespédès, G | 1 |
| Delbos, F | 1 |
| Horaud, T | 1 |
| Tarasi, A | 2 |
| Capone, A | 2 |
| Galié, M | 2 |
| Martino, P | 1 |
| Serra, P | 1 |
| Fernández Guerrero, ML | 1 |
| Núñez García, A | 1 |
| Caballero-Granado, FJ | 1 |
| Cisneros, JM | 1 |
| Luque, R | 1 |
| Torres-Tortosa, M | 1 |
| Gamboa, F | 1 |
| Díez, F | 1 |
| Villanueva, JL | 1 |
| Pérez-Cano, R | 1 |
| Pasquau, J | 1 |
| Merino, D | 1 |
| Menchero, A | 1 |
| Mora, D | 1 |
| López-Ruz, MA | 1 |
| Vergara, A | 1 |
| Marcus, N | 1 |
| Peled, N | 1 |
| Yagupsky, P | 1 |
| Bostic, G | 1 |
| Guirguitzova, B | 1 |
| Chankova, D | 1 |
| Zozikov, B | 1 |
| Minkov, N | 1 |
| Gulati, V | 1 |
| Aggarwal, A | 1 |
| Khanna, S | 1 |
| Narang, VK | 1 |
| Cassone, M | 1 |
| Tarasi, D | 1 |
| Brandimarte, C | 1 |
| Vogt, HB | 1 |
| Hoffman, WW | 1 |
| Ma, X | 1 |
| Takahashi, A | 1 |
| Johnson, AP | 2 |
| Warner, M | 1 |
| Speller, DC | 1 |
| Livermore, DM | 1 |
| Fogel, MA | 1 |
| Nussbaum, PB | 1 |
| Feintzeig, ID | 1 |
| Hunt, WA | 1 |
| Gavin, JP | 1 |
| Kim, RC | 1 |
| Messick, CR | 1 |
| Woodward, J | 1 |
| Pendland, SL | 1 |
| Locatelli, A | 1 |
| Adinolfi, LE | 1 |
| Andreana, A | 1 |
| Rambaldi, M | 1 |
| Ambrosone, L | 1 |
| Migliaresi, S | 1 |
| Rambaldi, A | 1 |
| Cirak, MY | 1 |
| Sultan, N | 1 |
| Kariyama, R | 2 |
| Kumon, H | 2 |
| Chow, L | 1 |
| Takata, T | 1 |
| Tabata, M | 1 |
| Onyeji, CO | 4 |
| Bow, L | 3 |
| Noskin, GA | 3 |
| Siddiqui, F | 1 |
| Stosor, V | 2 |
| Kruzynski, J | 1 |
| Peterson, LR | 2 |
| Torfoss, D | 1 |
| Aukrust, P | 1 |
| Brinch, L | 1 |
| Mathiesen, O | 1 |
| Axelsen, AK | 1 |
| Gaustad, P | 1 |
| Pfundstein, J | 1 |
| Roghmann, MC | 1 |
| Schwalbe, RS | 1 |
| Qaiyumi, SQ | 1 |
| McCarter, RJ | 1 |
| Keay, S | 1 |
| Schweitzer, E | 1 |
| Bartlett, ST | 1 |
| Morris, JG | 1 |
| Oldach, DW | 1 |
| Jensen, TG | 1 |
| Kolmos, HJ | 1 |
| Siboni, K | 1 |
| Hamilton-Miller, JMT | 1 |
| Shah, S | 1 |
| Viagappan, M | 1 |
| Holliman, RE | 1 |
| Bui, KQ | 1 |
| van Den Braak, N | 1 |
| Kreft, D | 1 |
| te Witt, R | 1 |
| Verbrugh, HA | 1 |
| Endtz, HP | 1 |
| Garavelli, PL | 1 |
| Descheemaeker, P | 1 |
| Ieven, M | 1 |
| Chapelle, S | 1 |
| Lammens, C | 1 |
| Hauchecorne, M | 1 |
| Wijdooghe, M | 1 |
| Vandamme, P | 1 |
| Goossens, H | 1 |
| Dressel, DC | 1 |
| Tornatore-Reuscher, MA | 1 |
| Boschman, CR | 1 |
| Zembower, T | 1 |
| Postelnick, MJ | 1 |
| Weinbren, MJ | 1 |
| Manzoor, SE | 1 |
| Fraise, AP | 1 |
| Gill, MJ | 1 |
| Courvalin, P | 2 |
| Suara, RO | 1 |
| Dermody, TS | 1 |
| Alexandrakis, G | 1 |
| Alfonso, EC | 1 |
| Miller, D | 1 |
| del Campo, R | 1 |
| Rubio, C | 1 |
| Castillo, J | 1 |
| Gómez-Lus, R | 1 |
| Kak, V | 1 |
| Farmaki, E | 1 |
| Roilides, E | 1 |
| Darilis, E | 1 |
| Tsivitanidou, M | 1 |
| Panteliadis, C | 1 |
| Sofianou, D | 1 |
| Tam, VH | 1 |
| Mckinnon, PS | 1 |
| Levine, DP | 1 |
| Brandel, SM | 1 |
| Rybak, MJ | 1 |
| Schouten, MA | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Meis, JF | 1 |
| Voss, A | 1 |
| Kurup, A | 1 |
| Tee, WS | 1 |
| Loo, LH | 1 |
| Lin, R | 2 |
| Brink, AJ | 1 |
| van den Ende, J | 1 |
| Routier, RJ | 1 |
| Devenish, L | 1 |
| Banevicius, MA | 1 |
| Li, J | 1 |
| Jones, JB | 1 |
| López, P | 1 |
| Martin, MT | 1 |
| Gomis, X | 1 |
| Azuaje, C | 1 |
| Borrell, N | 1 |
| Falcó, V | 1 |
| Duh, RW | 1 |
| Malathum, K | 1 |
| Bilikova, E | 1 |
| Gogova, M | 1 |
| Svetlansky, I | 1 |
| Lovaszova, M | 1 |
| Kadlubjakova, E | 1 |
| Pichnova, E | 1 |
| Krcmery, V | 1 |
| Jonas, JB | 1 |
| Lafaurie, M | 1 |
| Perichon, B | 1 |
| Sánchez-Silos, RM | 1 |
| Pérez-Giraldo, C | 1 |
| Blanco, MT | 1 |
| Morán, FJ | 1 |
| Hurtado, C | 1 |
| Gómez-García, AC | 1 |
| Papa, V | 1 |
| Aragona, P | 1 |
| Scuderi, AC | 1 |
| Blanco, AR | 1 |
| Zola, P | 1 |
| Di, BA | 1 |
| Santocono, M | 1 |
| Milazzo, G | 1 |
| Hachem, R | 1 |
| Raad, I | 1 |
| Thauvin-Eliopoulos, C | 1 |
| Moellering, RC | 1 |
| Ramos, MC | 1 |
| Grayson, ML | 1 |
| Bayer, AS | 1 |
| Wade, J | 1 |
| Baillie, L | 1 |
| Rolando, N | 1 |
| Casewell, M | 1 |
| Entenza, JM | 1 |
| Calandra, T | 1 |
| Moosmann, Y | 1 |
| Malinverni, R | 1 |
| Glauser, MP | 1 |
| Pouëdras, P | 1 |
| Leclercq, R | 1 |
| Donnio, PY | 1 |
| Sire, JM | 1 |
| Mesnard, R | 1 |
| Avril, JL | 1 |
| Urkijo, JC | 1 |
| Mendoza, MF | 1 |
| Aguirrebengoa, K | 1 |
| Hernández, JL | 1 |
| Aguirre, C | 1 |
| Hall, LM | 1 |
| Duke, B | 1 |
| Mazzulli, T | 1 |
| King, SM | 1 |
| Richardson, SE | 1 |
| King, JW | 1 |
| White, MC | 1 |
| Todd, JR | 1 |
| Conrad, SA | 1 |
| Jayarao, BM | 1 |
| Oliver, SP | 1 |
| Sherman, MD | 1 |
| Ostler, HB | 1 |
| Biswell, R | 1 |
| Cevallos, V | 1 |
| Desai, N | 1 |
| Casewell, MW | 1 |
| Wells, VD | 1 |
| Boonlayangoor, S | 1 |
| Baade, JL | 1 |
| Woods, GL | 1 |
| Till, M | 1 |
| Patterson, BK | 1 |
| Clarke, JT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Combination Treatment for Enterococcus Faecalis Bacteremia: a Prospective, Multicenter, Observational Study"[NCT04070820] | 500 participants (Anticipated) | Observational | 2019-09-01 | Recruiting | |||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for gentamicin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endocarditis | 2022 |
High-level Gentamicin Resistance among Clinical Isolates of Enterococci in Iran: a Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gentamicins; Gram-Positive Bacteria | 2021 |
Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections; | 2018 |
Lactobacillus paracasei endocarditis in a consumer of probiotics.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antimanic Agents; Arthroplasty, Replacement, Hip; Bacterem | 2013 |
Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Child; Child, Preschool; Enteral Nutrition | 2008 |
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Disease Models, Animal; Drug Inte | 2009 |
Antimicrobial-resistant enterococci in animals and meat: a human health hazard?
Topics: Animals; Anti-Infective Agents; DNA Transposable Elements; Drug Resistance, Bacterial; Enterococcus | 2010 |
Endocarditis caused by nutritionally variant streptococci: a case report and literature review.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bronchitis; Carnobacteriaceae; Disease Susceptibility; Dru | 2012 |
A woman with infectious endocarditis caused by Abiotrophia defectiva.
Topics: Aged; Anti-Bacterial Agents; Antihypertensive Agents; Endocarditis, Bacterial; Female; Fever; Gentam | 2004 |
Diagnosis and treatment of enterococcal endocarditis.
Topics: Aged; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faeciu | 1993 |
Aminoglycoside resistant enterococcal endocarditis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Com | 1993 |
[Enterococcal endocarditis, a model of therapeutic difficulty].
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Therapy, Co | 1995 |
Aminoglycoside resistance in enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Entero | 2000 |
4 trials available for gentamicin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplanta | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Fem | 1995 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Sq | 1999 |
Treatment of acute bacterial conjunctivitis with topical netilmicin.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Bacteria; Conjunctivitis, Bacterial; | 2002 |
260 other studies available for gentamicin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis; End | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenic | 2022 |
Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial | 2023 |
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endocarditis; Endocarditi | 2023 |
Topics: Agar; Animals; Anti-Bacterial Agents; Bacteria; Biliary Tract; Cattle; Cholangiocarcinoma; Drug Resi | 2023 |
Carbonic Anhydrase Inhibition as a Target for Antibiotic Synergy in Enterococci.
Topics: Animals; Anti-Bacterial Agents; Carbonic Anhydrases; Endocarditis, Bacterial; Enterococcus; Gentamic | 2023 |
High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gentamicins | 2019 |
In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Drug Synergism; Drug Th | 2020 |
Merulinic acid C overcomes gentamicin resistance in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Enterococcus faecium; Gentamicins | 2020 |
Prevalence of High-Level Aminoglycoside Resistance and Genes Encoding Aminoglycoside-Modifying Enzymes in Enterococcus faecalis and Enterococcus faecium Isolated in a University Hospital in Tokyo.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacter | 2020 |
Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Therap | 2020 |
First Danish case of infective endocarditis caused by
Topics: Administration, Intravenous; Anti-Bacterial Agents; Aortic Valve; Denmark; Drug Therapy, Combination | 2020 |
Aerococcus spp infective endocarditis following a prostate biopsy: a case report.
Topics: Aerococcus; Aged; Biopsy; Ceftriaxone; Echocardiography; Endocarditis; Female; Fever; Gentamicins; G | 2021 |
Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Enterococcus faeca | 2021 |
Induction of proteome changes involved in biofilm formation of Enterococcus faecalis in response to gentamicin.
Topics: Biofilms; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Proteome; | 2021 |
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Synerg | 2018 |
Postpartum infective endocarditis with Enterococcus faecalis in Japan: a case report.
Topics: Administration, Intravenous; Adult; Ampicillin; Anti-Bacterial Agents; Cesarean Section; Delayed Dia | 2017 |
In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Biofilms; Ceftaroline; Ceftriaxon | 2018 |
Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Urina | 2018 |
Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Electronic Health R | 2018 |
Structure analysis of transposons carrying the aac(6')-aph(2″) gene in Enterococcus faecalis isolated in Beijing, China, and comparison of their transfer efficiency.
Topics: Acetyltransferases; Anti-Bacterial Agents; Beijing; Chromosome Mapping; Conjugation, Genetic; DNA Tr | 2018 |
Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Drug Th | 2019 |
Ultrasound-activated microbubbles as a novel intracellular drug delivery system for urinary tract infection.
Topics: Anti-Bacterial Agents; Drug Delivery Systems; Enterococcus faecalis; Gentamicins; Gram-Positive Bact | 2019 |
Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature.
Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacte | 2019 |
Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Cross-Sectional Studies; Drug R | 2019 |
High Prevalence of the
Topics: Acetyltransferases; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Child | 2019 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Devi | 2013 |
Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Denmark; Endocarditis, Bacterial; En | 2013 |
Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Comb | 2013 |
High level of gentamicin resistance (HLGR) among enterococcus strains isolated from clinical specimens.
Topics: Acetyltransferases; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; El | 2013 |
Molecular characterization of high-level gentamicin-resistant Enterococcus faecalis from chicken meat in Korea.
Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-F | 2013 |
Combination therapy for enterococcal endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Reply to Gelfand et al and Solla.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Rigor in the design of observational noninferiority trials.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Gentamicin palmitate as a new antibiotic formulation for mixing with bone tissue and local release.
Topics: Allografts; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus subtilis; Bone and Bones; Bone T | 2014 |
Gentamicin once-daily in enterococcal endocarditis.
Topics: Aged; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gr | 2013 |
[Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Coho | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; D | 2014 |
The cement prosthesis-like spacer: an intermediate halt on the road to healing.
Topics: Arthritis, Infectious; Arthroplasty, Replacement, Knee; Bone Cements; Debridement; Enterococcus; Gen | 2013 |
[Spondylodiscitis and Lactococcus cremoris endocarditis].
Topics: Aged; Animals; Anti-Bacterial Agents; Bacteremia; Braces; Cattle; Combined Modality Therapy; Disciti | 2013 |
The majority of a collection of U.S. endocarditis Enterococcus faecalis isolates obtained from 1974 to 2004 lack capsular genes and belong to diverse, non-hospital-associated lineages.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cluster Analysis; Drug Resistance, Bacterial; Endocarditi | 2014 |
Antibiotic susceptibility in gram-positive chronic joint arthroplasty infections: increased aminoglycoside resistance rate in patients with prior aminoglycoside-impregnated cement spacer use.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replac | 2014 |
Fetal intestinal perforation and meconium peritonitis associated with maternal autoimmune hepatitis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Azathioprine; Enterococcus faecalis; Female; Gentamicins; | 2014 |
Prevalence and detection of mixed-population enterococcal bacteremia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Coinfection; Daptomycin; Enterococcus faecalis; | 2014 |
Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Drug Resist | 2014 |
Bacterial endocarditis following lithotripsy: an unusual complication caused by a non-invasive procedure.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Echocardiography; Endocarditis, Bacterial; Enterococcus fa | 2014 |
Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Topics: Ampicillin; Ampicillin Resistance; Bacteremia; Child; Child, Preschool; Cohort Studies; Cross Infect | 2015 |
In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Cathelicidins; Dap | 2015 |
[Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon].
Topics: Aged, 80 and over; Alloys; Amoxicillin; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Arter | 2015 |
Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Bacteremia; Baltimore; Child; Child, Prescho | 2015 |
Editorial Commentary: Pediatric Acute Kidney Injury: Is the Addition of Gentamicin Worth the Risk?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Gentamicins; Gram-Pos | 2015 |
Clinical and microbiological features of infective endocarditis caused by aerococci.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug | 2016 |
Granulicatella adiacens bacteremia after flexible sigmoidoscopy.
Topics: Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carnobacteriaceae; Gentamicins; Gr | 2016 |
Gentamicin induces efaA expression and biofilm formation in Enterococcus faecalis.
Topics: Antigens, Bacterial; Bacterial Proteins; Biofilms; Enterococcus faecalis; Gene Expression Regulation | 2016 |
Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacillus cereus; Cef | 2016 |
Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia.
Topics: Anti-Bacterial Agents; Birth Weight; Carrier State; Cesarean Section; Delivery, Obstetric; Drug Resi | 2016 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; A | 2016 |
Rare case of simultaneous enterococcal endocarditis and prosthetic joint infection.
Topics: Echocardiography, Transesophageal; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram | 2016 |
Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae.
Topics: Aerococcus; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Colony Count, Microbial; D | 2016 |
Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.
Topics: Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Drug Administration Schedule; Febr | 2016 |
Abiotrophia defectiva Endocarditis Complicated by Ventricular Tachycardia.
Topics: Abiotrophia; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Drug Therapy, Combinat | 2016 |
Prevalence of high-level gentamicin-resistant
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gent | 2016 |
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ascites; Cephalosporins; Cohort Studies; Enterococcus; Fema | 2009 |
[Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Thera | 2008 |
[Propionibacterium acnes endocarditis on an aortic prosthesis in a patient carrying a pacemaker].
Topics: Abscess; Aged; Amoxicillin; Anti-Bacterial Agents; Aortic Valve; Bacteremia; Combined Modality Thera | 2008 |
Transposon Tn5281 is the main distributor of the aminoglycoside modifying enzyme gene among isolates of Enterococcus faecalis in Tehran hospitals.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Ele | 2008 |
Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Child; Child, Preschool; Drug Re | 2008 |
High-level gentamicin-resistant and vancomycin-resistant Enterococcus faecium isolated from a wound in a dog.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Dog Diseases; Dogs; Drug Resistance, Multiple, Bac | 2009 |
Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Creatinine; Denmark; Endocarditis; Enterococcus; Female; | 2009 |
Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Debridement; | 2009 |
Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant.
Topics: Aortic Diseases; Bacteremia; Diseases in Twins; Drug Resistance, Multiple, Bacterial; Enterococcus f | 2009 |
Assessment of high-level gentamicin and glycopeptide-resistant Enterococcus faecalis and E. faecium clonal structure in a Portuguese hospital over a 3-year period.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Cluster Analysis; DNA Finger | 2009 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacte | 2009 |
[Enterococcal meningitis in adults].
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Enterococcus | 2009 |
Clonal groups of high-level gentamicin-resistant Enterococcus faecium isolated from municipal wastewater and clinical samples in Tehran, Iran.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; DNA, Bacte | 2009 |
Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital.
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; DNA Transposable Elements; Drug Resistan | 2009 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporin | 1981 |
Late infection of an embolized renal graft presented as buttock cellulitis.
Topics: Ampicillin; Anti-Bacterial Agents; Buttocks; Cellulitis; Embolization, Therapeutic; Enterococcus fae | 2010 |
Chronic suppurative otitis media in cleft palate: microorganism etiology and susceptibilities.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Chronic Disease; Ciprof | 2009 |
Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Re | 2010 |
Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark.
Topics: Animals; Anti-Bacterial Agents; Denmark; Disease Reservoirs; Drug Resistance, Bacterial; Electrophor | 2010 |
Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Gentamicins; Gentian Violet; Gram-Positi | 2010 |
Mobile aortic valve vegetation in a patient with infective endocarditis due to Enterococcus: ECG-gated 64-slice MDCT findings.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Aortic Valve; Cholecystectomy, Laparoscopic; Drug Therapy, | 2010 |
Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn.
Topics: Acetamides; Anti-Bacterial Agents; Cerebral Ventricles; Cerebrospinal Fluid; Chloramphenicol; Enceph | 2010 |
Gentamicin-resistant Enterococcus faecalis sequence type 6 with reduced penicillin susceptibility: diagnostic and therapeutic implications.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Denmark; Drug Resistance, Bacterial; Enterococcus fae | 2010 |
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacteriolysis; Colony Count, Microbial; Endocarditis, B | 2011 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Pos | 2010 |
Endogenous endophthalmitis caused by Enterococcus casseliflavus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Endophthalmitis; Enterococcus; Eye Infections, | 2011 |
Management of gram-positive coccal bacteremia and hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; En | 2011 |
Lactococcus garvieae causing zoonotic prosthetic valve endocarditis.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography, Transesophageal; Endoca | 2011 |
Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacitracin; Biofilms; Cefa | 2011 |
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Gentam | 2011 |
A survey on the use of gentamicin in infective endocarditis.
Topics: Anti-Bacterial Agents; Drug Therapy; Endocarditis; France; Gentamicins; Gram-Positive Bacterial Infe | 2012 |
Molecular characterisation of high-level gentamicin-resistant enterococci from bloodstream infections in Denmark: first description of clonal spread of aph(2'')-Ib.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Denmark; Drug Resistance, Bacterial; Enterococcus; | 2012 |
The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Administratio | 2012 |
Increased high-level gentamicin resistance in invasive Enterococcus faecium is associated with aac(6')Ie-aph(2″)Ia-encoding transferable megaplasmids hosted by major hospital-adapted lineages.
Topics: Acetyltransferases; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Enterococcus | 2012 |
Cerebrospinal fluid shunt infection due to Gemella haemolysans.
Topics: Adolescent; Anti-Bacterial Agents; Causality; Ceftazidime; Central Nervous System Infections; Dandy- | 2013 |
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antis | 2013 |
Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Cohort S | 2013 |
Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Endocarditis; Female; Gentamicins; Gram-Positive Bac | 2013 |
Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA | 2002 |
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Utilization; Electrop | 2003 |
Livedo reticularis associated with the use of a midline catheter.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Enterococcus faecalis; Gentami | 2002 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangio | 2003 |
Molecular characterization of gentamicin-resistant Enterococci in the United States: evidence of spread from animals to humans through food.
Topics: Animal Diseases; Animals; Animals, Domestic; Drug Resistance, Bacterial; Enterococcus; Feces; Food M | 2003 |
High-level gentamicin resistance in Enterococcus faecium and Enterococcus faecalis blood culture isolates from 23 European university hospitals.
Topics: Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive | 2003 |
Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Drug Resistance, Bacterial; Enterococcus; Gentamicins; Gra | 2003 |
Facial necrotizing fasciitis following acute dacryocystitis.
Topics: Abscess; Acute Disease; Combined Modality Therapy; Dacryocystitis; Debridement; Drug Therapy, Combin | 2003 |
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial | 2003 |
Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; Disease Models, Animal; E | 2003 |
Structures, locations, and transfer frequencies of genetic elements conferring high-level gentamicin resistance in Enterococcus faecalis isolates in Greece.
Topics: Acetyltransferases; Anti-Bacterial Agents; Chromosomes, Bacterial; Conjugation, Genetic; DNA Transpo | 2003 |
Enterococcus durans endocarditis in a patient with transposition of the great vessels.
Topics: Adult; Ampicillin; Biofilms; Ceftriaxone; Drug Therapy, Combination; Endocarditis, Bacterial; Entero | 2004 |
Pulmonary homograft endocarditis after Ross procedure.
Topics: Adult; Ampicillin; Aortic Valve; Bioprosthesis; Combined Modality Therapy; Drug Therapy, Combination | 2004 |
Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in the south east of Sweden 1994-2001.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Drug Resistance, Bacterial; Electrophoresis, | 2004 |
Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
Topics: Aged; Ampicillin; Ceftriaxone; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, | 2004 |
Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bile; Carbon-Oxygen Ligases; Cross-Sectional Studies; Dru | 2004 |
Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands.
Topics: Carrier State; Drug Resistance, Bacterial; Enterococcus; Gentamicins; Gram-Negative Bacteria; Gram-N | 2004 |
Genetic characterization of high-level gentamicin-resistant strains of Enterococcus faecalis in Iran.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Deoxyribonuclease EcoRI; DNA Fingerprinting; DNA, Bacte | 2004 |
Drug resistance of Enterococcus faecium clinical isolates and the conjugative transfer of gentamicin and erythromycin resistance traits.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; | 2005 |
Detection of the esp gene in high-level gentamicin resistant Enterococcus faecalis strains from pet animals in Japan.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cat Diseases; Cats; DNA, Bacterial; Dog Diseases | 2005 |
Gentamicin induced ototoxicity during treatment of enterococcal endocarditis: resolution with substitution by netilmicin.
Topics: Aged; Anti-Bacterial Agents; Endocarditis, Bacterial; Equipment Contamination; Gentamicins; Gram-Pos | 2005 |
Colonization by high-level aminoglycoside-resistant enterococci in intensive care unit patients: epidemiology and clinical relevance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cohort Studies; Cross Infection; DNA Fingerprinting; DNA, Ba | 2005 |
Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital.
Topics: Acetyltransferases; Anti-Infective Agents; Bacterial Proteins; China; DNA Primers; Electrophoresis, | 2006 |
Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combina | 2006 |
Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chromosomes, Bacterial; DNA, B | 2005 |
[Meningitis caused by Enterococcus faecalis during disseminated anguilluliasis].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antiparasitic Agents; Bronchoalveolar Lavage Fluid; Cer | 2006 |
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous | 2006 |
Infective endocarditis and spondylodiscitis in a patient due to Aerococcus urinae: first report.
Topics: Aged; Anti-Bacterial Agents; Discitis; Drug Therapy, Combination; Endocarditis; Follow-Up Studies; G | 2007 |
Occurrence of aminoglycoside-modifying-enzyme genes aac(6')-aph(2"), aph(3'), ant(4') and ant(6) in clinical isolates of Enterococcus faecalis resistant to high-level of gentamicin and amikacin.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistanc | 2006 |
Multilocus sequence typing of hospital-associated Enterococcus faecium from Brazil reveals their unique evolutionary history.
Topics: Alleles; Ampicillin Resistance; Brazil; Colony Count, Microbial; Cross Infection; Disease Outbreaks; | 2006 |
Diversity of structures carrying the aac(6')-aph(2") gene in clinical Enterococcus faecalis and Enterococcus faecium strains isolated in Tunisia.
Topics: Acetyltransferases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Drug Resistance | 2006 |
[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Topics: Aged; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; | 2006 |
[Liver abscess and infective endocarditis cases caused by Ruminococcus productus].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Gentam | 2006 |
In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Enterococcus; Enzyme Inhibitors; | 2007 |
High-level gentamicin-resistant Enterococcus faecium strains isolated from bone marrow transplant patients: accumulation of antibiotic resistance genes, large plasmids and clonal strain dissemination.
Topics: Anti-Bacterial Agents; Bone Marrow Transplantation; DNA, Bacterial; Drug Resistance, Bacterial; Elec | 2007 |
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Synergism; Enterococcus faecalis; Genta | 2007 |
Leuconostoc species-associated endocarditis.
Topics: Anti-Bacterial Agents; Aortic Valve; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gentamicin | 2007 |
Detection of virulence factors in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolates from a Tunisian hospital.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; Biofilms; Caco-2 Cells; Cell Line; Dr | 2007 |
A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Cross Infection; Daptomycin; Drug Resistan | 2007 |
Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacte | 2007 |
A nanoplex PCR assay for the rapid detection of vancomycin and bifunctional aminoglycoside resistance genes in Enterococcus species.
Topics: Aminoglycosides; Anti-Bacterial Agents; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Ent | 2007 |
Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococ | 2008 |
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri | 2008 |
The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents--a preliminary report.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Drug Resistance, Microbial; Enterococcus faecium; | 1995 |
Lactobacillus fermentum endocarditis involving a native mitral valve.
Topics: Adolescent; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Gram-Positive B | 1995 |
Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
Topics: Adult; Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditi | 1995 |
Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin.
Topics: Bacteremia; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Epidemiologic Methods | 1995 |
Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons.
Topics: Bacterial Proteins; Base Sequence; Biomarkers; DNA, Bacterial; Drug Resistance, Microbial; Endocardi | 1995 |
Community-acquired enterococcal meningitis in an adult.
Topics: Adult; Ampicillin; Community-Acquired Infections; Enterococcus faecalis; Gentamicins; Gram-Positive | 1995 |
Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis.
Topics: Base Sequence; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecal | 1995 |
A survey of antimicrobial susceptibility of clinical isolates of Enterococcus spp. from Irish hospitals.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gentamicins; Gram- | 1995 |
Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Ceftriaxone; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocar | 1995 |
Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains.
Topics: Ampicillin; Animals; Bacterial Toxins; Dexamethasone; Electroretinography; Endophthalmitis; Enteroco | 1995 |
Endocarditis due to high level gentamicin resistant Enterococcus faecium.
Topics: Aged; Aged, 80 and over; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; | 1994 |
Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents.
Topics: Conjugation, Genetic; DNA Probes; DNA Restriction Enzymes; DNA Transposable Elements; Drug Resistanc | 1993 |
Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bact | 1993 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides | 1994 |
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; | 1993 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; D | 1993 |
High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
Topics: Drug Synergism; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sen | 1993 |
Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
Topics: Aged; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus fa | 1993 |
Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Cross Infection; Disease Outbreaks; DNA, Bacter | 1993 |
Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis.
Topics: Adult; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacteri | 1993 |
Synergy characterization for Enterococcus faecalis strains displaying moderately high-level gentamicin and streptomycin resistance.
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Gentam | 1993 |
Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Child; Child, Preschool; Drug Resistance, Mi | 1993 |
Frequency and antimicrobial susceptibility of clinical isolates of enterococci.
Topics: Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; | 1993 |
Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; | 1993 |
Increasing problems in the therapy of enterococcal infections.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Positive Bact | 1993 |
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Topics: Ampicillin; Animals; Aortic Valve; beta-Lactamases; Disease Models, Animal; Drug Resistance, Microbi | 1993 |
Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance.
Topics: DNA Restriction Enzymes; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enterococcus faecali | 1993 |
Treatment of infections due to enterococci with high-level gentamicin resistance and streptomycin susceptibility.
Topics: Drug Resistance, Microbial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; | 1993 |
Use of gentamicin for treatment of enterococcal infections.
Topics: Endocarditis, Bacterial; Enterococcus; Gentamicins; Gram-Positive Bacterial Infections; Humans | 1993 |
Achieving bactericidal therapy and high-level aminoglycoside resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; G | 1993 |
Characterization of antimicrobial resistance in enterococci of animal origin.
Topics: Animals; Anti-Bacterial Agents; Birds; Cattle; Chickens; Drug Resistance, Microbial; Enterococcus; F | 1995 |
[Spondylodiscitis caused by Enterococcus: an unusual entity].
Topics: Aged; Amoxicillin; Combined Modality Therapy; Diabetes Mellitus, Type 2; Discitis; Drug Therapy, Com | 1995 |
High-level gentamicin resistance among enterococci.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Cross Infection; DNA Transposable Elements; DNA, Bacter | 1995 |
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Comb | 1995 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug T | 1996 |
Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Computer Simulation; Culture Media; Drug Administration | 1996 |
Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; DNA Restriction Enzymes; Drug Resistance, M | 1996 |
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Cont | 1995 |
Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Computer Simulation; Drug Synergism; Drug Therapy, Comb | 1996 |
Incidence of high-level gentamicin resistance in enterococci at Johannesburg Hospital.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gent | 1996 |
Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, | 1997 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; D | 1997 |
High-level plasmid-mediated gentamicin resistance and pheromone response of plasmids present in clinical isolates of Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Blotting, Southern; Chromosome Mapping; Drug Resistance, Microbial; Electroph | 1997 |
Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacteremia; Cluster Analysis; Cross Infection; Disease | 1997 |
Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis; Enterococcus fae | 1997 |
Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Clindamycin; Debridement; | 1997 |
Genetic and molecular characterization of high-level gentamicin resistance in Enterococcus faecalis strains isolated in Romania.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Entero | 1997 |
Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Bactericidal Activity; Drug Therapy, Combinati | 1997 |
Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization; Cross Infection; Drug Resistance, M | 1998 |
Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Blood; Drug Resistance, Microbial; Drug Resistance, Mu | 1997 |
Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Carrier State; Communi | 1998 |
Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Hea | 1998 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactama | 1998 |
Biochemical speciation of enterococci causing human infections.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Drug Resistance, Microbial; Enteroco | 1997 |
Fatal suppurative mesenteric thrombophlebitis caused by an Enterococcus faecalis highly resistant to aminoglycosides: case report.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecalis; Fatal Outcome; | 1998 |
A case of Lactobacillus acidophilus endocarditis successfully treated with cefazolin and gentamicin.
Topics: Anti-Bacterial Agents; Cefazolin; Endocarditis, Bacterial; Female; Gentamicins; Gram-Positive Bacter | 1998 |
Evidence of nosocomial infection in Japan caused by high-level gentamicin-resistant Enterococcus faecalis and identification of the pheromone-responsive conjugative plasmid encoding gentamicin resistance.
Topics: Conjugation, Genetic; Cross Infection; Crosses, Genetic; DNA, Bacterial; Drug Resistance, Microbial; | 1998 |
Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; E | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combina | 1998 |
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Syner | 1998 |
Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
Topics: Aged; Ampicillin; Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Endo | 1998 |
In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
Topics: Amikacin; Ampicillin; Animals; Dibekacin; DNA Primers; DNA Probes; DNA Restriction Enzymes; Drug Res | 1998 |
Infective endocarditis presenting as polyarthritis.
Topics: Adult; Arthritis; Drug Resistance, Microbial; Echocardiography; Electrocardiography; Endocarditis, B | 1998 |
Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococ | 1998 |
In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Ther | 1998 |
Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils.
Topics: Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faeca | 1999 |
Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Comb | 1999 |
Carrier rate of resistant enterococci in a tertiary care hospital in Norway.
Topics: Aged; Anal Canal; Bacterial Proteins; beta-Lactam Resistance; Carbon-Oxygen Ligases; Carrier State; | 1999 |
Resistance problems in two university hospitals in Denmark.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Denmark; Drug Resistance, Microbial; Drug Utilization; | 1999 |
Identification of clinically isolated vancomycin-resistant enterococci: comparison of API and BBL Crystal systems.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Microbial; Enterococcus faecium | 1999 |
Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Microbial; | 1999 |
Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice.
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus | 1999 |
The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Culture Media; DNA, Bacterial; Drug Resistance, Microbial; | 1999 |
[Bacteremia caused by Bacillus sphaericus].
Topics: Adult; Ampicillin; Bacillus; Bacteremia; Blood; Drug Therapy, Combination; Female; Gentamicins; Gram | 1999 |
Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; Carbon-Oxygen Ligases; Enterococcus; Genes, Bact | 2000 |
Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines.
Topics: Ampicillin; Anti-Bacterial Agents; Clinical Laboratory Techniques; Drug Synergism; Enterococcus; Gen | 1999 |
Defining high-level gentamicin resistance in enterococci.
Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Gentamicins; Gram-Po | 2000 |
Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Microbial; | 2000 |
Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Endocarditis, Bacterial; Enterococcus faecal | 2000 |
Enterococcal meningitis in an infant complicating congenital cutis aplasia.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ectodermal Dysplasia; Enterococcus faecalis; Gentamic | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R | 2000 |
Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Gentamicins; Gram | 2000 |
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug | 2000 |
Gemella morbillorum endocarditis in a child.
Topics: Child; Drug Therapy, Combination; Echocardiography, Doppler; Endocarditis, Bacterial; Female; Follow | 2000 |
Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus f | 2000 |
Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review.
Topics: Adult; Aged; Ampicillin; Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faeca | 2000 |
Prevalence of vancomycin-resistant enterococci in Europe.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterococcus; Europe; Femal | 2000 |
Infection of central nervous system by motile Enterococcus: first case report.
Topics: Aged; Central Nervous System Bacterial Infections; Drug Therapy, Combination; Enterococcus; Fever; G | 2001 |
A case of vancomycin-resistant enterococcal endocarditis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins | 2000 |
Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Drug Resistance, Multiple; Drug Therapy, Combination; Ent | 2001 |
Postoperative Proprionobacterium acnes endophthalmitis.
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacter | 2001 |
Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
Topics: Animals; Disease Models, Animal; Drug Combinations; Endocarditis, Bacterial; Enterococcus faecalis; | 2001 |
In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus | 2001 |
Clinical significance of high-level gentamicin resistance in enterococci causing bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus; Gentamicins; Gram-Posit | 2001 |
Postoperative proprionibacterium acnes endophthalmitis.
Topics: Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gentamic | 2001 |
Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Thera | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross In | 2001 |
The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Carrier State; Drug Resistance, Multiple, Bacterial; F | 2002 |
Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Case-Contro | 2002 |
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Mic | 1992 |
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bac | 1992 |
Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin.
Topics: Child; Drug Resistance, Microbial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infect | 1992 |
Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus fae | 1992 |
Bacteremia due to vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin.
Topics: Ampicillin; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Female; Gentamicins; Gram- | 1992 |
[Endocarditis caused by Lactobacillus].
Topics: Adult; Clindamycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Gram-Po | 1992 |
Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom.
Topics: Cluster Analysis; Cross Infection; DNA Fingerprinting; Drug Resistance, Microbial; Enterococcus faec | 1992 |
Bacteremia due to beta-lactamase-producing Enterococcus faecalis with high-level resistance to gentamicin in a child with Wiskott-Aldrich syndrome.
Topics: Bacteremia; Child, Preschool; Drug Resistance, Microbial; Enterococcus faecalis; Gentamicins; Gram-P | 1992 |
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside.
Topics: Amikacin; Bacteremia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negative | 1992 |
Aminoglycoside-resistant Streptococcus and Enterococcus species isolated from bovine mammary secretions.
Topics: Animals; Anti-Bacterial Agents; Cattle; Conjugation, Genetic; Drug Resistance, Microbial; Enterococc | 1992 |
Enterococcus faecalis infection in a corneal graft.
Topics: Chloramphenicol; Corneal Ulcer; Drug Therapy, Combination; Enterococcus faecalis; Eye Infections, Ba | 1992 |
Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae.
Topics: Adult; Chlorhexidine; Cross Infection; Disease Outbreaks; Drug Evaluation; Drug Resistance, Microbia | 1991 |
Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis.
Topics: beta-Lactamases; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbia | 1992 |
Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Evaluation Studies as Topi | 1991 |
Enterococci highly resistant to penicillin: characterizing isolates from Singapore hospitals.
Topics: Cross Infection; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Hospitals; | 1991 |
Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
Topics: Animals; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacter | 1991 |
High-level gentamicin resistance in Enterococcus faecalis bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheterization, Peripheral; Cros | 1991 |